ACRV Sale Disclosure
Gamelin Erick · SEC Form 4 · Filed Aug 20, 2026
Sale
Calculated transaction value
$804
Gamelin Erick Chief Development Officer
ACRV
Transaction date
Aug 18, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 2 days later
ACRV daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 400 shares @ $2.01
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000905148-26-003838
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$804
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Acrivon Therapeutics, Inc. ACRV Current | Sale | Aug 18, 2026 | $804 |